Janchor Partners is a private equity firm headquartered in Hong Kong.
It was founded in 2009 by a team of experienced investment professionals with a deep understanding of the Asian market.
The firm focuses on investing in mid-market and growth-stage companies in China, Southeast Asia, and India.
Janchor Partners has raised three funds to date, with a total of over $1 billion in capital commitments.
The firm’s investment strategy is to partner with management teams to help them grow their businesses and achieve their strategic goals.
Janchor Partners provides its portfolio companies with capital, strategic guidance, and operational support.
Some of the notable investments of Janchor Partners include:
- MediTrust Health: A leading healthcare provider in China.
- Abbisko Therapeutics: A clinical-stage biopharmaceutical company developing treatments for Alzheimer’s disease.
- Ameego: A leading online travel platform in Southeast Asia.
- GuocoLand Limited: A leading property developer in Singapore.
- New Hope Liuhe Co., Ltd: A leading agri-business company in China.
Private Equity Firms Hong Kong
Janchor Partners has a strong track record of success and has helped its portfolio companies achieve significant growth.
The firm is well-positioned to continue to invest in and support the growth of Asian companies in the years to come.
Here are some additional information about Janchor Partners:
- The firm’s current CEO is John Chan.
- Janchor Partners has raised over $1 billion in capital.
- The firm’s portfolio companies have a combined market capitalization of over $5 billion.
- Janchor Partners is a member of the Asia Pacific Private Equity Association (AIPA).
